It is known not only for its culinary value, but its medicinal significance as well
During periods of reduced carbohydrate intake, the liver produces ketones from fat breakdown
Clinical studies of incretin receptor agonists provide evidence of cardiovascular benefit, but they do not directly demonstrate anti-fibrotic effects, as fibrosis has not been measured as a primary outcome in major trials
CONCLUSION The analysis of GLP-1 products, such as semaglutide and tirzepatide, reveals how a financialized pharmaceutical business modelexorbitant pricing, patent abuse, and restricted insurance coverageperpetuate health inequities and limit access to critical treatments
[8] [9] However, the emergence of GLP-1 receptor agonists (glucagon-like peptide-1 analogues) has opened new therapeutic possibilities
Together, they represent a comprehensive approach to tissue repairaddressing both structural reorganization and cellular protection/signaling